SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
250 11 0 PLI.TO
Emcee:  axial Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
225PROMETIC PROVIDES CORPORATE UPDATE LAVAL, QUEBEC, CANADA, – November 28, 2018 axial-11/28/2018
224PROMETIC REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS Extension oaxial-11/14/2018
223PROMETIC CLOSES ITS EXTENSION OF DEBT MATURITIES TO 2024 Maturity Dates of the axial-11/14/2018
222PROMETIC TO REPORT ITS THIRD QUARTER 2018 FINANCIAL RESULTS AND HOLD CONFERENCE axial-11/12/2018
221COMMENT Since July Prometic's affairs have become more complicated aaxial-11/12/2018
220PROMETIC ANNOUNCES EXTENSION OF DEBT MATURITIES TO 2024 Maturity Date of Line ofaxial-10/29/2018
219PROMETIC ANNOUNCES POSITIVE FEEDBACK FROM FDA TYPE-C MEETING ON RYPLAZIM (PLASMIaxial-10/16/2018
218PROMETIC TO HOST KEY OPINION LEADER MEETING ON PBI-4050, A NOVEL TREATMENT FOR axial-9/5/2018
217PROMETIC REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AD HIGHLIGHTS Advanced maxial-8/15/2018
216PROMETIC ANNOUNCES THE PUBLICATION OF PBI-4050’s ANTIFIBROTIC ACTIVITY IN LIVERaxial-8/10/2018
215ANALYSIS — Echelon Wealth (PDF) PBI-4050 Grows In Status, This Time With FDA-Coaxial-8/9/2018
214ACTUAL volume (Canada) [graphic] TSX reports 1,152.8 trades — ACTUAL volume iaxial-8/7/2018
213ANALYSIS - Hybridian (PDF) Strong momentum can close significant valuation gap axial-8/7/2018
212PROMETIC TO REPORT ITS SECOND QUARTER 2018 FINANCIAL RESULTS AND HOLD CONFERENCEaxial-8/7/2018
211PROMETIC RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM U.S. FDA FOR SMALL MOLaxial-8/7/2018
210The Wrap - July 2018 — 26 July this was a Stockhouse post: ' I expeaxial-8/7/2018
209COMMENT — Mystery buyer(s) have appeared. Explanations are all over the map. Haaxial-7/27/2018
208The retrace — 12 July [graphic] PFSCF [graphic] Jimaxial-7/12/2018
207Trading 11 July 2018 [graphic] PFSCF — [graphic] Jimaxial-7/12/2018
206A different view — There's been a storm of negativity arising from Prometicaxial-7/11/2018
205Prometic conference call to present progress report on AGM corporate action planaxial-6/22/2018
204PROMETIC PRESENTS NEW DATA ON NASH DRUG CANDIDATE PBI-4547 New data suggest PBIaxial-6/22/2018
203CORRECTION — COMPANY OVERVIEW: JUNE, 2018 (PDF) prometic.com Jimaxial-6/8/2018
202COMPANY OVERVIEW, JUNE 2018 - Prometic Life Sciences www.prometic.com/wp-conteaxial-6/7/2018
201A 3-Way Race To The Next Generation IPF Drug: Galapagos, FibroGen, ProMetic Sumaxial15/23/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News